Celularity Reports Quarterly Earnings and Institutional Buying Activity
1 report, 1 independent
Updated Oct 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Celularity reported $0.02 earnings per share and $5.43 million in revenue for the quarter. Following the earnings release, Celularity stock traded down 17.9% during midday trading on Wednesday, reaching $1.03. Separately, C V Starr & Co. Inc. purchased 764,069 shares of Celularity stock during the second quarter, valued at approximately $1,582,000.
From tickerreport.com
Why it matters
The company's earnings and subsequent stock movement reflect market sentiment regarding its financial performance. The institutional purchase by C V Starr & Co. Inc. represents a notable increase in ownership, with the firm now holding 2.64% of Celularity.
From tickerreport.com
Who's involved
- SECRegulatory body overseeing company filings
Keep exploring
The entities involved
-
SEC
Slovak company
Related events
- Insider purchase disclosed via SEC filing for Transcontinental Realty Investors, Inc. on August 6, 2026.
- SEC filing relates to stock traded on Nasdaq.
- PPL disclosed a stock sale in a legal filing with the SEC.
- A company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.
- Data I/O Corporation filed acquisition documents with the SEC following significant stock purchases by major shareholders and institutional investors.